---
title: Matregenix announced a winner of the 2022 Medical Innovation Challenge at Defense TechConnect Innovation Summit
description: Matregenix announced a winner of the 2022 Medical Innovation Challenge at Defense TechConnect Innovation Summit
---

[![logo-new-2](https://www.matregenix.com/hubfs/Theme_2023/images/logo-new-2.svg "logo-new-2")](https://matregenix.com)

- [Home](https://www.matregenix.com/nanofiber-solutions)
- [About Us](https://www.matregenix.com/about-us)
- [Technology](https://www.matregenix.com/nanofiber-technology)
- [Contract Development](https://www.matregenix.com/contract-design-and-development)
- Products 
    - [Biomedical](https://www.matregenix.com/biomedical-technology)
    - [Filtration](https://www.matregenix.com/filtration-technology)
    - [Machinery](https://www.matregenix.com/nanofiber-electrospinning)
- More 
    - [Quality Assurance](https://www.matregenix.com/nanofiber-quality-assurance)
    - [Blog](https://www.matregenix.com/blog)
    - [News](https://www.matregenix.com/news)
    - [Career](https://www.matregenix.com/career)
    - [Request Quote](https://www.matregenix.com/request-quote)
    - [Financing Options](https://www.matregenix.com/nanofiber-electrospinning-machine-financing)
    - [Financial Conflict of Interest (FCOI) Policy](https://www.matregenix.com/financial-conflict-of-interest-fcoi-policy)
    - [EPM](https://www.matregenix.com/epm)
    - [Distributor](https://www.matregenix.com/distributors)
- [Contact Us](https://www.matregenix.com/contact-us)

# Matregenix announced a winner of the 2022 Medical Innovation Challenge at Defense TechConnect Innovation Summit

Advanced Technology International (ATI), TechConnect and four MedTech industry consortia today announced Matregenix as a winner of the 2022 Medical Innovation Challenge at the Defense TechConnect Innovation Summit. The award comes with $25k cash prize and access to consortia that represent $20B in defense contracting authority. This award is sponsored by [ATI | Advanced Technology International, Medical Technology Enterprise Consortium, Countering Weapons of Mass Destruction Consortium, and SHIC | Senior Healthcare Innovation Consortium](##) in honor of innovation with the potential to help solve our nation’s most critical medical and health tech challenges.

![](https://www.matregenix.com/hs-fs/hubfs/Theme_2023/images/img%20(8).png?width=426&height=371&name=img%20(8).png)

Held Sept. 27-29, 2022, at Gaylord National Hotel & Convention Center in National Harbor, Md., Defense TechConnect is the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements. Dr. Sherif Soliman, the CEO of Matregenix pitched the company’s new developed platform technology for soft-tissue repair applications.

###### Share This Story, Choose Your Platform!

- <https://www.facebook.com/sharer/sharer.php?u=https://www.matregenix.com/news/matregenix-announced-a-winner-of-the-2022-medical-innovation-challenge-at-defense-techconnect-innovation-summit&title=Matregenix%20announced%20a%20winner%20of%20the%202022%20Medical%20Innovation%20Challenge%20at%20Defense%20TechConnect%20Innovation%20Summit&picture=&description=Matregenix%20announced%20a%20winner%20of%20the%202022%20Medical%20Innovation%20Challenge%20at%20Defense%20TechConnect%20Innovation%20Summit>
- <http://www.linkedin.com/shareArticle?mini=true&url=https://www.matregenix.com/news/matregenix-announced-a-winner-of-the-2022-medical-innovation-challenge-at-defense-techconnect-innovation-summit&title=Matregenix%20announced%20a%20winner%20of%20the%202022%20Medical%20Innovation%20Challenge%20at%20Defense%20TechConnect%20Innovation%20Summit&summary=Matregenix%20announced%20a%20winner%20of%20the%202022%20Medical%20Innovation%20Challenge%20at%20Defense%20TechConnect%20Innovation%20Summit>

[Matregenix Announces Phase 1 SBIR Grant Award from National Institutes of Health](https://www.matregenix.com/news/matregenix-announced-a-winner-of-the-2022-medical-innovation-challenge-at-defense-techconnect-innovation-summit-0) [MATREGENIX LANDS DUAL SBIR AND STTR CONTRACTS WITH AIR FORCE FOR ADVANCED NANOFIBER BIOMEDICAL TECHNOLOGIES](https://www.matregenix.com/news/matregenix-lands-dual-sbir-and-sttr-contracts-with-air-force-for-advanced-nanofiber-biomedical-technologies)

[![logo-new 1](https://www.matregenix.com/hubfs/Theme_2023/images/logo-new%201.svg "logo-new 1")](https://matregenix.com/)

- [Home](https://www.matregenix.com/nanofiber-solutions)
- [About Us](https://www.matregenix.com/about-us)
- [Technology](https://www.matregenix.com/nanofiber-technology)
- [Biomedical](https://www.matregenix.com/biomedical-technology)
- [Filtration](https://www.matregenix.com/filtration-technology)
- [Machinery](https://www.matregenix.com/nanofiber-electrospinning)
- [Contract Development](https://www.matregenix.com/contract-design-and-development)
- [News](https://www.matregenix.com/news)
- [Blog](https://www.matregenix.com/blog)

<https://www.instagram.com/matregenix/?hl=en> <https://www.facebook.com/matregenix/> <https://x.com/matregenix> <https://www.linkedin.com/company/matregenix>

**Contact us: [(617) 763-6334](tel:%20(617)%20763-6334)**

<https://www.matregenix.com/news/matregenix-announced-a-winner-of-the-2022-medical-innovation-challenge-at-defense-techconnect-innovation-summit#page-top>

[Privacy Policy](https://www.matregenix.com/privacy-policy)

Copyright © 2026 - Matregenix. All rights reserved.

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin",
    "url" : "https://www.matregenix.com/news/author/admin"
  },
  "dateModified" : "2023-03-01T20:52:00.125Z",
  "datePublished" : "2022-10-13T07:58:00.000Z",
  "headline" : "Matregenix announced a winner of the 2022 Medical Innovation Challenge at Defense TechConnect Innovation Summit",
  "mainEntityOfPage" : {
    "@id" : "https://www.matregenix.com/news/matregenix-announced-a-winner-of-the-2022-medical-innovation-challenge-at-defense-techconnect-innovation-summit",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.matregenix.com/hubfs/Logo-01-Mar-06-2023-11-46-36-7770-PM.png"
    },
    "name" : "Matregenix"
  }
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.matregenix.com/#organization",
  "@type" : "Organization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "US",
    "addressLocality" : "Mission Viejo",
    "addressRegion" : "CA",
    "postalCode" : "92691",
    "streetAddress" : "26021 Pala, Suite A"
  },
  "brand" : [ {
    "@type" : "Brand",
    "name" : "Matregenix"
  }, {
    "@type" : "Brand",
    "name" : "ElectrospinTek",
    "url" : "https://www.electrospintek.com"
  } ],
  "description" : "Matregenix is a US-based nanofiber CDMO. We develop and manufacture electrospun nanofiber membranes for filtration and biomedical applications, from R&D to roll-to-roll production, and build electrospinning machines under the ElectrospinTek brand.",
  "email" : "info@matregenix.com",
  "founder" : {
    "@type" : "Person",
    "name" : "Sherif Soliman"
  },
  "knowsAbout" : [ "electrospinning", "nanofiber membranes", "PFAS-free filter media", "nanofiber contract manufacturing", "tissue engineering scaffolds", "electrospinning machines" ],
  "legalName" : "Matregenix, Inc.",
  "logo" : "https://www.matregenix.com/hubfs/23649008/Theme_2023/images/logo-new-2.svg",
  "name" : "Matregenix",
  "sameAs" : [ "https://www.linkedin.com/company/matregenix", "https://www.electrospintek.com", "https://x.com/matregenix", "https://www.instagram.com/matregenix/", "https://www.facebook.com/matregenix/" ],
  "telephone" : "+1-617-763-6334",
  "url" : "https://www.matregenix.com"
}
```